Cargando…
The validation of published utility mapping algorithms: an example of EORTC QLQ-C30 and EQ-5D in non-small cell lung cancer
BACKGROUND: Mapping algorithms can be used to generate health state utilities when a preference-based instrument is not included in a clinical study. Our aim was to investigate the external validity of published mapping algorithms in non-small cell lung cancer (NSCLC) between the EORTC QLQ-C30 and E...
Autores principales: | Gregory, Joanne, Dyer, Matthew, Hoyle, Christopher, Mann, Helen, Hatswell, Anthony J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175479/ https://www.ncbi.nlm.nih.gov/pubmed/32319016 http://dx.doi.org/10.1186/s13561-020-00269-w |
Ejemplares similares
-
Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma
por: Proskorovsky, Irina, et al.
Publicado: (2014) -
Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients
por: Kim, Seon Ha, et al.
Publicado: (2012) -
Testing mapping algorithms of the cancer-specific EORTC QLQ-C30 onto EQ-5D in malignant mesothelioma
por: Arnold, David T, et al.
Publicado: (2015) -
Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer
por: Gray, Laura A., et al.
Publicado: (2021) -
Mapping the EORTC QLQ-C30 and QLQ-H&N35 to the EQ-5D for head and neck cancer: Can disease-specific utilities be obtained?
por: Beck, Ann-Jean C. C., et al.
Publicado: (2019)